Stable Relapsing Multiple Sclerosis

CME

Video

Expert Insights on COVID-19 Prophylaxis in Patients With Multiple Sclerosis and Related Disorders

1.50 CME

1.50 NCPD

90 MINS

$0 FEE

Clinical Guidance

Multiple Sclerosis

Overview

Pathophysiology

Pavan Bhargava, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance

Multiple Sclerosis

Overview

Etiology and Risk Factors

Pavan Bhargava, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance

Multiple Sclerosis

Overview

Global Prevalence and Epidemiology

Pavan Bhargava, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

News

April 30, 2024

2 min read

Save

Novel gold therapeutic linked to improved outcomes in MS at 96 weeks

DENVER — Daily treatment with a suspension of gold crystals was linked to improved outcomes at 96 weeks for those with stable relapsing multiple sclerosis, according to a speaker at the American Academy of Neurology annual meeting.